Defective Medicines Reaching Patients

Public confidence in Hong Kong's pharmaceutical supply chain has been shattered. A series of scandals exposed deficiencies in numerous links, including manufacturers, wholesalers, procurers and prescribers. A review is underway and findings are expected before the end of 2009. BMI believes regulations will be tightened and the frequency of inspections

To read the full article, please choose one of the following options: